Illumina

Front End Engineer Tech Lead

Toronto, Ontario, Canada

Not SpecifiedCompensation
Expert & Leadership (9+ years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
AdTech, MarTechIndustries

Requirements

The ideal candidate should possess a Master’s degree in Software Engineering, Computer Science, or a related field, along with 8+ years of hands-on software development experience utilizing TypeScript, React, Node.js, and Next.js. Furthermore, they must have 8+ years of experience working with MySQL and 5+ years of experience in AdTech, MarTech, or related industries, complemented by 3+ years of tech leadership experience. Proficiency in Kafka, Aerospike, Druid, and HBase is also required, alongside a deep understanding of ECMAScript, Web APIs, HTML, and CSS.

Responsibilities

As a Front End Engineer Tech Lead, you will design, develop, and deploy system-wide frameworks to be leveraged by feature teams, build in-house development tools to improve developer efficiency, explore and evaluate new technologies, provide technical leadership for the Front-End Engineering team, collaborate with cross-functional teams, own end-to-end feature development, drive critical architecture and technology decisions, conduct thorough code reviews, and optimize the performance of web applications.

Skills

TypeScript
React
Node.js
Next.js
MySQL
Kafka
Aerospike
Druid
HBase
ECMAScript
Web APIs
HTML
CSS
Technical Documentation
Communication
Analytical Skills
Problem-Solving
Web Application Performance Optimization
Front-end Architecture
End-to-end Solution Implementation

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI